Please assess the completion status of the following clinical trial:

Trial Title: ProAlgaZyme Novel Algae Infusion: Applications in Metabolic Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Participants must meet 3 of the following criteria:~  * BMI ≥30 kg/m2~ * HDL Cholesterol of \<40~ * Triglycerides \>150 mg/dl~ * Fasting blood glucose \>100 mg/dl~ * Blood pressure \>130/85 mm Hg~ * Total Cholesterol of \>200 mg/dl~ * LDL Cholesterol of \>160 mg/dl~ * Interleukin 6 (IL-6) \>5pg/mL~Exclusion Criteria:~* Morbidly obese: BMI \>40 kg/m2~* Taking any cholesterol-lowering medications 30 days prior to the start of enrollment and during the course of the study.~* Enrolled in another clinical study in the past 6 months.~* Pregnant, actively infected, on medication that interfered with healing (for example, steroids), were inflicted with systemic disease such as AIDS, HIV, active hepatitis or active malignancy (clinical signs within the past 5 years), or suffered from diabetes mellitus requiring daily insulin management.

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).